|
Volumn 721, Issue 2, 1999, Pages 279-284
|
Development and validation of a sensitive solid-phase extraction and high-performance liquid chromatography assay for the novel antitumour agent CT2584 in human plasma
|
Author keywords
1 (11 Dodecylamino 10 hydroxyundecyl) 3; 7 Dimethylxanthine; CT2584
|
Indexed keywords
1 (11 DODECYLAMINO 10 HYDROXYUNDECYL) 3,7 DIMETHYLXANTHINE;
ANTINEOPLASTIC AGENT;
CT 2584;
UNCLASSIFIED DRUG;
ARTICLE;
CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
HUMAN;
HUMAN TISSUE;
INTRAVENOUS DRUG ADMINISTRATION;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
TECHNIQUE;
ANTINEOPLASTIC AGENTS;
BUFFERS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
HUMANS;
INDICATORS AND REAGENTS;
NEOPLASMS;
REPRODUCIBILITY OF RESULTS;
XANTHINES;
|
EID: 0033001894
PISSN: 13872273
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4347(98)00491-5 Document Type: Article |
Times cited : (4)
|
References (12)
|